DSIP (5mg)

DSIP (Delta Sleep-Inducing Peptide) — 5mg | Research Grade | Australia

DSIP is a naturally occurring 9 amino acid neuropeptide first isolated in 1974 from the cerebral blood of rabbits exhibiting deep delta wave sleep — making it the first substance ever extracted from brain tissue specifically for its observed sleep-promoting properties. It crosses the blood-brain barrier and interacts with NMDA receptors and multiple neurotransmitter systems including GABA, serotonin, dopamine, and noradrenaline. Available from Austides in research-grade lyophilised form, third-party tested and domestically dispatched from Australia.

Research Applications

• Examined in animal studies for its effects on slow-wave (delta) sleep architecture, with researchers observing increases in sleep percentage and reductions in sleep latency in preclinical models

• Studied in preclinical and early human research settings for its influence on stress hormone modulation, including effects on corticotropin (ACTH) release and HPA axis regulation

• Investigated for its effects on neuroendocrine function, including interactions with GHRH, somatostatin, and luteinising hormone release pathways in preclinical models

• Subject of preclinical research into antioxidant and cytoprotective mechanisms in animal models

• Examined in animal research for its observed antagonistic effects on opiate receptor pathways and influence on dependency-related behaviour models

Product Specifications

Austides Standard

All Austides peptides are third-party tested for purity and potency. Domestically dispatched from Australia with discrete, secure packaging and cold-chain integrity maintained throughout.

For research purposes only. Not for human consumption, therapeutic use, or self-administration. This product is not approved by the TGA for any therapeutic application.